Literature DB >> 3225634

Tumor cord and growth in human brain tumors based on mathematical morphology.

Y Yoshii1, K Narushima, K Tsuboi, Y Maki, K Sugiyama.   

Abstract

The growth of human brain tumor was quantitatively investigated by using the anti-bromodeoxyuridine (BrdU) monoclonal antibody and the texture analyzing system (TAS). Tissues from thirty eight patients consisting of 22 gliomas, 8 brain metastases, 1 cerebellar hemangioblastoma and 7 normal white matters were applied in this study. Mean values of growth fractions (GFs) were 29.4% in group 1, 14.8% in group 2, and 6.5% in group 3. The higher value of GFs showed a significantly larger degree of perivascular aggregation of S-phase cells (DPAS). The mean number of cells in each tumor cord was approximately 20, which is not significantly larger than that of the normal group. But there was a significant difference between the non-selected area of the histologically malignant or benign gliomas and the proliferating area of the biologically malignant or benign brain tumors (t-value; p less than 0.001). A significant difference was also noticed in the mean area and diameter of tumor cords (t-value; p less than 0.001). From the point of view of biological behavior in human brain tumor, it is suggested that one tumor cord contains approximately 20 viable cells in the proliferating area in both benign and malignant brain tumors, and that if viable cells increase to more than 20 cells in one TC, necrotic cells and the diameter and area of the TC will increase, because the vessel-density is decreased by the occlusion of the vessels and the death of the endothels.

Entities:  

Mesh:

Year:  1988        PMID: 3225634     DOI: 10.1007/bf02327387

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

Review 1.  Vascular structures in brain tumors.

Authors:  A Hirano; T Matsui
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

2.  Cell kinetics of human gliomas.

Authors:  T Hoshino; M Barker; C B Wilson; E B Boldrey; D Fewer
Journal:  J Neurosurg       Date:  1972-07       Impact factor: 5.115

3.  Distribution of cell doubling times in in vivo human cerebral tumors.

Authors:  R Tym
Journal:  Surg Forum       Date:  1969

4.  Endothelium stimulating factor from Walker carcinoma cells. Relation to tumor angiogenic factor.

Authors:  B R McAuslan; H Hoffman
Journal:  Exp Cell Res       Date:  1979-03-01       Impact factor: 3.905

5.  Tumour cell proliferation in relation to the vasculature.

Authors:  D G Hirst; J Denekamp
Journal:  Cell Tissue Kinet       Date:  1979-01

6.  Drug delivery to CNS tumors.

Authors:  V A Levin; H D Landahl; C S Patlak
Journal:  Cancer Treat Rep       Date:  1981

7.  Estimation of rate of growth of malignant brain tumors by computed tomography scanning.

Authors:  T Yamashita; T Kuwabara
Journal:  Surg Neurol       Date:  1983-12

8.  Induction of sister chromatid exchanges by BUdR is largely independent of the BUdR content of DNA.

Authors:  R L Davidson; E R Kaufman; C P Dougherty; A M Ouellette; C M DiFolco; S A Latt
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

9.  The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier.

Authors:  D J Cox; G J Pilkington; P L Lantos
Journal:  Br J Exp Pathol       Date:  1976-08

10.  The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis.

Authors:  B R Deane; P L Lantos
Journal:  J Neurol Sci       Date:  1981-01       Impact factor: 3.181

View more
  2 in total

1.  Rapid estimation of the proliferating index of brain tumours.

Authors:  A Detta; E Hitchcock
Journal:  J Neurooncol       Date:  1990-06       Impact factor: 4.130

2.  Nuclear morphometry and DNA densitometry of human gliomas by image analysis.

Authors:  Y Yoshii; A Saito; T Nose
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.